Germany· DE-A57-61006c5ea677876e
Levocabastin
A medicinal product containing levocabastine hydrochloride, registered in Germany by Dermapharm Ag.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Levocabastine Hydrochloride
- Manufacturer
- Dermapharm Ag
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levocabastine hydrochloride in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLivostin 0.05% nasal sprayNovartis Pharmaceuticals UK Ltd
- FranceALLERGIFLASH 0,05 %, collyre en solutionLABORATOIRE CHAUVIN
- SwedenLivocab 50 mikrogram/dos Nässpray, suspensionOrifarm AB
- FinlandLivostinParanova Oy
- BelgiumLivostin 0.5 mg/mlOrifarm
- IcelandLivostinMcNeil Sweden AB
- SpainBILINA 0,5 mg/ml COLIRIO EN SUSPENSIÓNEsteve Pharmaceuticals S.A.
- NorwayLivostin2care4 ApS
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Levocamed, Livostin
- Belgium · Livostin, Nasasinuspray Anti-Allergie
- Czechia · Livostin
- Denmark · Benaliv
- Spain · Bilina, Reactine
- Finland · Livostin
- France · Allergiflash, Levofree
- Greece · Livostin
- Iceland · Livostin
- Italy · Levoreact, Levoreact Oftalmico
- Luxembourg · Livostin, Nasasinuspray Anti-Allergie
- Netherlands · Livocab
- Norway · Livostin
- Sweden · Livostin
- Slovakia · Livostin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe347669-2e17-4f6e-8750-a956eca1f0f2 GET /v1/drugs/fe347669-2e17-4f6e-8750-a956eca1f0f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Nasal Use, Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Levocabastine Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about levocabastine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.